Literature DB >> 29045701

Regulatory T Cells Contribute to HIV-1 Reservoir Persistence in CD4+ T Cells Through Cyclic Adenosine Monophosphate-Dependent Mechanisms in Humanized Mice In Vivo.

Guangming Li1, Jun-Ichi Nunoya1, Liang Cheng1, Natalia Reszka-Blanco1, Li-Chung Tsao1, Jerry Jeffrey2, Lishan Su1,3.   

Abstract

Background: Regulatory T cells (Tregs) suppress T-cell immune activation and human immunodeficiency virus type 1 (HIV-1) replication, but the role of Tregs in HIV-1 reservoir persistence is poorly defined.
Methods: Tregs were depleted by denileukin diftitox in humanized mice with chronic HIV-1 infection. Viral replication in lineage cells was determined by p24 expression. Levels of HIV-1 RNA and DNA in human cells, as well as replication-competent-virus-producing cells, were measured to quantified viral replication and reservoirs.
Results: Treg depletion resulted in a blip of HIV-1 replication in T cells but not in myeloid cells. The major activated reservoir cells were memory CD4+ T cells in vivo. Interestingly, the transient activation of viral replication led to HIV-1 reservoir reduction after viremia resuppression, as indicated by the quantity of HIV-1 DNA and replication-competent-virus-producing cells. Furthermore, we demonstrated that Tregs use cyclic adenosine monophosphate (cAMP)-dependent protein kinase A pathway to inhibit HIV-1 activation and replication in resting conventional T cells in vitro.
Conclusion: Tregs suppress HIV-1 replication in T cells and contribute to HIV-1 reservoir persistence. cAMP produced in Tregs is involved in their suppression of viral gene activation and expression. Treg depletion combined with combination antiretroviral therapy provides a novel strategy for HIV-1 cure.
© The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  HIV-1; Tregs; antiviral treatment; cART-resistant reservoir; chronic infection

Mesh:

Substances:

Year:  2017        PMID: 29045701      PMCID: PMC5853220          DOI: 10.1093/infdis/jix547

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  48 in total

1.  HIV latency in the humanized BLT mouse.

Authors:  Matthew D Marsden; Michael Kovochich; Nuttee Suree; Saki Shimizu; Roshni Mehta; Ruth Cortado; Gregory Bristol; Dong Sung An; Jerome A Zack
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

2.  Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells.

Authors:  Janet D Siliciano; Joleen Kajdas; Diana Finzi; Thomas C Quinn; Karen Chadwick; Joseph B Margolick; Colin Kovacs; Stephen J Gange; Robert F Siliciano
Journal:  Nat Med       Date:  2003-05-18       Impact factor: 53.440

3.  Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene.

Authors:  J Kimpton; M Emerman
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

4.  Rapid phenotypic drug susceptibility assay for HIV-1 with a CCR5 expressing indicator cell line.

Authors:  M Pirounaki; N A Heyden; M Arens; L Ratner
Journal:  J Virol Methods       Date:  2000-03       Impact factor: 2.014

5.  HIV DNA Is Frequently Present within Pathologic Tissues Evaluated at Autopsy from Combined Antiretroviral Therapy-Treated Patients with Undetectable Viral Loads.

Authors:  Susanna L Lamers; Rebecca Rose; Ekaterina Maidji; Melissa Agsalda-Garcia; David J Nolan; Gary B Fogel; Marco Salemi; Debra L Garcia; Paige Bracci; William Yong; Deborah Commins; Jonathan Said; Negar Khanlou; Charles H Hinkin; Miguel Valdes Sueiras; Glenn Mathisen; Suzanne Donovan; Bruce Shiramizu; Cheryl A Stoddart; Michael S McGrath; Elyse J Singer
Journal:  J Virol       Date:  2016-09-29       Impact factor: 5.103

6.  Human regulatory T cells are targets for human immunodeficiency Virus (HIV) infection, and their susceptibility differs depending on the HIV type 1 strain.

Authors:  Maria E Moreno-Fernandez; Wildeman Zapata; Jason T Blackard; Genoveffa Franchini; Claire A Chougnet
Journal:  J Virol       Date:  2009-10-14       Impact factor: 5.103

7.  Generation of HIV latency in humanized BLT mice.

Authors:  Paul W Denton; Rikke Olesen; Shailesh K Choudhary; Nancy M Archin; Angela Wahl; Michael D Swanson; Morgan Chateau; Tomonori Nochi; John F Krisko; Rae Ann Spagnuolo; David M Margolis; J Victor Garcia
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

8.  Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function.

Authors:  M K Levings; R Sangregorio; M G Roncarolo
Journal:  J Exp Med       Date:  2001-06-04       Impact factor: 14.307

9.  Cyclic adenosine monophosphate is a key component of regulatory T cell-mediated suppression.

Authors:  Tobias Bopp; Christian Becker; Matthias Klein; Stefan Klein-Hessling; Alois Palmetshofer; Edgar Serfling; Valeska Heib; Marc Becker; Jan Kubach; Steffen Schmitt; Sabine Stoll; Hansjörg Schild; Martin S Staege; Michael Stassen; Helmut Jonuleit; Edgar Schmitt
Journal:  J Exp Med       Date:  2007-05-14       Impact factor: 14.307

10.  HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells.

Authors:  Kyra Oswald-Richter; Stacy M Grill; Nikki Shariat; Mindy Leelawong; Mark S Sundrud; David W Haas; Derya Unutmaz
Journal:  PLoS Biol       Date:  2004-07-13       Impact factor: 8.029

View more
  14 in total

1.  Specific Activation In Vivo of HIV-1 by a Bromodomain Inhibitor from Monocytic Cells in Humanized Mice under Antiretroviral Therapy.

Authors:  Guangming Li; Zheng Zhang; Natalia Reszka-Blanco; Feng Li; Liqun Chi; Jianping Ma; Jerry Jeffrey; Liang Cheng; Lishan Su
Journal:  J Virol       Date:  2019-05-29       Impact factor: 5.103

Review 2.  Regulatory T cells (Tregs): A major immune checkpoint to consider in combinatorial therapeutic HIV-1 vaccines.

Authors:  Audrey Hubert; Nabila Seddiki
Journal:  Hum Vaccin Immunother       Date:  2018-02-23       Impact factor: 3.452

Review 3.  Recent progress in understanding HIV reservoirs.

Authors:  Hsiao-Hsuan Kuo; Mathias Lichterfeld
Journal:  Curr Opin HIV AIDS       Date:  2018-03       Impact factor: 4.283

4.  Phenotypic and Functional Study of Human Plasmacytoid Dendritic Cells.

Authors:  Guangming Li; Liang Cheng; Lishan Su
Journal:  Curr Protoc       Date:  2021-04

Review 5.  Regulatory T Cells As Potential Targets for HIV Cure Research.

Authors:  Adam J Kleinman; Ranjit Sivanandham; Ivona Pandrea; Claire A Chougnet; Cristian Apetrei
Journal:  Front Immunol       Date:  2018-04-13       Impact factor: 7.561

6.  Analysis of the dysregulation between regulatory B and T cells (Breg and Treg) in human immunodeficiency virus (HIV)-infected patients.

Authors:  Carolina Gutiérrez; Jacobo Lopez-Abente; Verónica Pérez-Fernández; Adrián Prieto-Sánchez; Rafael Correa-Rocha; Santiago Moreno-Guillen; María-Ángeles Muñoz-Fernández; Marjorie Pion
Journal:  PLoS One       Date:  2019-03-27       Impact factor: 3.240

7.  Chimeric Antigen Receptor T Cell Bearing Herpes Virus Entry Mediator Co-stimulatory Signal Domain Exhibits High Functional Potency.

Authors:  Jun-Ichi Nunoya; Michiaki Masuda; Chaobaihui Ye; Lishan Su
Journal:  Mol Ther Oncolytics       Date:  2019-03-23       Impact factor: 7.200

8.  Potential Role of Regulatory T Cells in Mother-to-Child Transmission of HIV.

Authors:  Peter A Kessler
Journal:  Curr HIV Res       Date:  2018       Impact factor: 1.581

Review 9.  Harnessing regulatory T cell neuroprotective activities for treatment of neurodegenerative disorders.

Authors:  Jatin Machhi; Bhavesh D Kevadiya; Ijaz Khan Muhammad; Jonathan Herskovitz; Katherine E Olson; R Lee Mosley; Howard E Gendelman
Journal:  Mol Neurodegener       Date:  2020-06-05       Impact factor: 14.195

10.  HIV-1 elite controllers present a high frequency of activated regulatory T and Th17 cells.

Authors:  Diogo G Caetano; Hury H S de Paula; Gonzalo Bello; Brenda Hoagland; Larissa M Villela; Beatriz Grinsztejn; Valdilea G Veloso; Mariza G Morgado; Monick L Guimarães; Fernanda H Côrtes
Journal:  PLoS One       Date:  2020-02-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.